Objectives: To investigate the prevalence, typology, and experience of urinary incontinence, as well as the available therapeutic modalities and information sources among people living at home in Belgium. Methods: A representative population sample of 5,269 adults completed a questionnaire in their own homes. There were 2,499 men and 2,770 women aged 30 years and over. Results: 130 men (5.2%) and 442 women (16.30%) had urinary incontinence at the time of the survey. Of 1,426 women aged over 50 years, 300(21.0%) had urinary incontinence. 17.4% of the incontinent people experience several episodes daily. In women, incontinence increases with parity. Stress incontinence is by far the most common form of the disease (42%); 53% of incontinent women (9.9% of the female population) experience this kind of disorder. Overall, 95% of stress incontinent people are women. The relative frequency of urge incontinence is similar in both sexes (males 45%; females 55%). Urinary incontinence is considered as bothersome by about 30% of the affected subjects; 7 of 10 subjects with daily incontinence episodes consider the disorder as more or less bothersome. 29.9% of affected people report that they discuss the problem with their general practitioner, 11.4% with a specialist,25.3% with their spouse or partner, and 17.4% with a family member. Of course, people who consider the disease as bothersome score higher on these items. On the other hand, 32.1% do not reveal the problem. Although 72.5%of incontinent people are aware of protection systems, the main therapeutic modalities are not very well known (drugs 33.9%; surgery 24.7%). Most people with incontinence (70-75%) take no specific measures, 20% use pads, panty liners or nappies, and only 9% look for a curative measure. The preferred information source is the family physician for 50%, the specialist physician for 11%, and the pharmacist for 9%. The role of the mass media is equivalent to that of specialist physicians and pharmacists. Conclusions: Incontinence has a profound effect on daily life, and is still considered by many as ‘taboo’. An appropriate information system, in which the general practitioner plays a key role, is obviously desirable.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.